It is typically prescribed for people with a higher body mass index (BMI) , or for those with a BMI of 27 or above who also have a weight-related health condition , such as high blood pressure or type 2 diabetes
A 2025 meta-analysis in JACC encompassing 99,599 patients demonstrated reductions in all-cause death, cardiovascular death, MACE, myocardial infarction, and heart failure hospitalization with high-certainty evidence
Key Takeaways Yes retatrutide causes some muscle (lean mass) loss, but it is not selectively "eating" your muscle
Those with type 3 also experience neurological complications
Book your specialist consultation in Dubai If you are ready to find out whether Ozempic, Wegovy, Mounjaro, Foundayo , or another option is right for your metabolic picture, book a specialist consultation at our Dubai Healthcare City clinic